Wanted pages

From Longevity Wiki

List of non-existing pages with the most links to them, excluding pages which only have redirects linking to them. For a list of non-existent pages that have redirects linking to them, see the list of broken redirects.

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Quercetin‏‎ (5 links)
  2. Inflammaging‏‎ (4 links)
  3. Barzilai, N., Appleby, J. C., Austad, S. N., Cuervo, A. M., Kaeberlein, M., Gonzalez-Billault, C., ... & Sierra, F. (2020). Geroscience in the Age of COVID-19. Aging and disease, 11(4), 725.‏‎ (3 links)
  4. Promislow, D. E. (2020). A geroscience perspective on COVID-19 mortality. The Journals of Gerontology: Series A, 75(9), e30-e33.‏‎ (3 links)
  5. Sierra, F. (2020). Geroscience and the Coronavirus Pandemic: The Whack‐a‐Mole Approach is not Enough. Journal of the American Geriatrics Society, 68(5), 951.‏‎ (3 links)
  6. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current opinion in psychiatry, 32(5), 381.‏‎ (2 links)
  7. Cell Competition‏‎ (2 links)
  8. Crimmins, E. M., Kim, J. K., & Seeman, T. E. (2009). Poverty and biological risk: the earlier “aging” of the poor. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences, 64(2), 286-292.‏‎ (2 links)
  9. Gensous, N., Bacalini, M. G., Franceschi, C., & Garagnani, P. (2020, July). Down syndrome, accelerated aging and immunosenescence. In Seminars in Immunopathology (pp. 1-11). Springer Berlin Heidelberg.‏‎ (2 links)
  10. O’Keeffe, L. M., Taylor, G., Huxley, R. R., Mitchell, P., Woodward, M., & Peters, S. A. (2018). Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ open, 8(10), e021611.‏‎ (2 links)
  11. Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., ... & Goldacre, B. (2020). Factors associated with COVID-19-related death using OpenSAFELY. Nature, 584(7821), 430-436.‏‎ (2 links)
  12. Yegorov, Y. E., Poznyak, A. V., Nikiforov, N. G., Sobenin, I. A., & Orekhov, A. N. (2020). The link between chronic stress and accelerated aging. Biomedicines, 8(7), 198.‏‎ (2 links)
  13. Advanced glycation end product (AGE)‏‎ (1 link)
  14. Age-related diseases‏‎ (1 link)
  15. Aging-associated diseases‏‎ (1 link)
  16. Bcl-2 antiapoptotic family proteins‏‎ (1 link)
  17. Berberine‏‎ (1 link)
  18. Body mass index‏‎ (1 link)
  19. CVD (cardiovascular disease)‏‎ (1 link)
  20. Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019). From discoveries in ageing research to therapeutics for healthy ageing. Nature, 571(7764), 183-192.‏‎ (1 link)
  21. Chronic kidney disease‏‎ (1 link)
  22. Crimmins, E. M. (2011). Beltrán-‐Sánchez, H.(2010). Mortality and morbidity trends: Is there compression of morbidity. Journal of Gerontology: Social Sciences, 66B, 1.‏‎ (1 link)
  23. Diabetes mellitus type 2‏‎ (1 link)
  24. Doi (identifier)‏‎ (1 link)
  25. Dynamometer‏‎ (1 link)
  26. FOXO4‏‎ (1 link)
  27. Follicle-stimulating hormone (FSH)‏‎ (1 link)
  28. ISBN (identifier)‏‎ (1 link)
  29. Insulin sensitivity‏‎ (1 link)
  30. Jin, K., Simpkins, J. W., Ji, X., Leis, M., & Stambler, I. (2015). The critical need to promote research of aging and aging-related diseases to improve health and longevity of the elderly population. Aging and disease, 6(1), 1.‏‎ (1 link)
  31. Jin, K. (2010). Modern biological theories of aging. Aging and disease, 1(2), 72.‏‎ (1 link)
  32. Kaeberlein, M. (2014). Rapamycin and aging: when, for how long, and how much?. Journal of genetics and genomics= Yi chuan xue bao, 41(9), 459.‏‎ (1 link)
  33. Klotho‏‎ (1 link)
  34. Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., ... & Fontana, L. (2015). Interventions to slow aging in humans: are we ready?. Aging cell, 14(4), 497-510.‏‎ (1 link)
  35. Margolick, J. B., & Ferrucci, L. (2015). Accelerating aging research: how can we measure the rate of biologic aging?. Experimental gerontology, 64, 78-80.‏‎ (1 link)
  36. NF-κΒ‏‎ (1 link)
  37. Neoplasms‏‎ (1 link)
  38. Niacin‏‎ (1 link)
  39. Nicotinamide (NAM)‏‎ (1 link)
  40. Nicotinamide mononucleotide (NMN)‏‎ (1 link)
  41. Nicotinamide riboside (NR)‏‎ (1 link)
  42. Ocampo, A., Reddy, P., Martinez-Redondo, P., Platero-Luengo, A., Hatanaka, F., Hishida, T., ... & Belmonte, J. C. I. (2016). In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell, 167(7), 1719-1733.‏‎ (1 link)
  43. Ogden, L. E. (2019). Travels through Time. BioScience, 69(11), 860-866.‏‎ (1 link)
  44. P53‏‎ (1 link)
  45. PMID (identifier)‏‎ (1 link)
  46. Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020). The quest to slow ageing through drug discovery. Nature Reviews Drug Discovery, 19(8), 513-532.‏‎ (1 link)
  47. Rae, M. J., Butler, R. N., Campisi, J., De Grey, A. D., Finch, C. E., Gough, M., ... & Logan, B. J. (2010). The demographic and biomedical case for late-life interventions in aging. Science translational medicine, 2(40), 40cm21-40cm21.‏‎ (1 link)
  48. Rejuvenation‏‎ (1 link)
  49. SASP‏‎ (1 link)
  50. Senomorphic‏‎ (1 link)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)